
Biogliz M 1mg/500mg Tablet
Marketer
Biocore Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Biogliz M 1mg/500mg Tablet
Glimepiride/Metformin 1mg/500mg tablets are classified as antidiabetic medications. This dual-drug formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should consult their physician prior to use. Pregnant or lactating women require medical consultation before initiating treatment. Regular blood glucose monitoring is necessary, and your doctor might recommend blood tests to assess blood cell counts and liver function.
Uses of Biogliz M 1mg/500mg Tablet
Managing Type 2 Diabetes
Major Benefits of Biogliz M 1mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Biogliz M 1mg/500mg tablets should be taken with a meal.
Common Side effects of Biogliz M 1mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Biogliz M 1mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Biogliz M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Biogliz M 1mg/500mg Tablet works:
Biogliz M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Biogliz M 1mg/500mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Biogliz M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation and Biogliz M 1mg/500mg tablets are incompatible; the medication poses a potential risk of infant toxicity.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Biogliz M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Biogliz M 1mg/500mg tablets are contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Biogliz M 1mg/500mg Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate liver disease, initiation should be at a low dosage; however, Biogliz M 1mg/500mg Tablets are contraindicated in those with severe liver dysfunction.
What if you forget to take Biogliz M 1mg/500mg Tablet :
Should you forget a Biogliz M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Biogliz M 1mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
